Lallemand joins EuropaBio: new global opportunities for industrial biotechnology

Brussels, 19 May 2021 – EuropaBio is pleased to announce that Lallemand has joined as a corporate member.

Founded in Canada over a century ago, today the company employs over 4500 people with a world-wide presence.

Lallemand has a proprietary collection of thousands of individually identified strains of yeast and bacteria. With the goal of reproducing, managing, and optimizing natural fermentation processes, Lallemand offers its customers not only the precise microorganism(s) and or derivative(s) that fit their specific needs, but also the support, knowledge, and expertise that comes with over a hundred years of continuous improvements, research, development and innovation in microbial industrialisation.

As part of EuropaBio, it will contribute to enabling best practices and access to wholesome, safe, sustainable, nutritious, and healthy food and or products, ensuring that animals and humans lead healthy lives and make our world a generally better one.

EuropaBio Director-General Dr. Claire Skentelbery says “Lallemand is a fantastic addition to the EuropaBio community, bringing next generation industrial biotechnology to life for the revolution in sustainability that we need to deliver the Green Deal. Their expertise and multi-sector experience sits at the core of EuropaBio activities and mission.

Lallemand’s Executive Vice President and COO, Bill Nankervis, added “At Lallemand we are passionate about biotechnology and the potential to create value and improve the environment and the quality of life of people (and animals) across the World. We are committed to our customers and partners in Europe and it makes sense to contribute to assuring the advancement of industrial biotechnology through membership of EuropaBio”.